(Q38232792)

31 August 2017

The economic burden of psoriasis: a systematic literature review (English)

1 reference

31 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

Smeet Gala

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

4

Merena Nanavaty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Chakkarin Burudpakdee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Usha G Mallya

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

23 July 2014

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

685-705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of psoriasis: a systematic review of incidence and prevalence

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Moderate and severe plaque psoriasis: cost-of-illness study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Economic burden of moderate to severe plaque psoriasis in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Clinical, economic, and humanistic burden of asthma in Canada: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

An Italian study on psoriasis and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Smoking and alcohol intake in severely affected patients with psoriasis in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

The burden of moderate to severe psoriasis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Economic burden of psoriasis compared to the general population and stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Biologics in the treatment of psoriasis: clinical and economic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

The direct cost of care for psoriasis and psoriatic arthritis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

The direct healthcare insurer and out-of-pocket expenditures of psoriasis: evidence from a United States national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Medication use and associated health care outcomes and costs for patients with psoriasis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Infliximab for inpatient psoriasis management--is there a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

Recent trends in systemic psoriasis treatment costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.933671

10.1586/14737167.2014.933671

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25052261%20AND%20SRC:MED&resulttype=core&format=json

release_nk3uq6yifncs7bh2v5m5tnjlqm

13 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nk3uq6yifncs7bh2v5m5tnjlqm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference